INS and Hypoglycemia: Of importance to glycemic control in T2DM, GLP-1 acts on the islet β-cell GLP-1R to potentiate insulin secretion in a glucose-dependent manner, greatly reducing the risk for hypoglycemia compared to other insulin secretagogues.